Trial Profile
Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2013
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm
- Focus Therapeutic Use
- Sponsors Allergan
- 18 Nov 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00761592).
- 14 Jun 2011 New trial record